AAP
AMED

Arax Advisory Partners’s Amedisys AMED Stock Holding History

Arax Advisory Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-115
Closed -$11.3K – 3621
2025
Q2 		$11.3K Sell
115
-17
-13% -$1.61K ﹤0.01% 1908
2025
Q1 		$12.2K Sell
132
-1,187
-90% -$109K ﹤0.01% 1498
2024
Q4 		$120K Buy
1,319
+1,264
+2,298% +$116K 0.01% 623
2024
Q3 		$5.31K Buy
+55
New +$5.37K ﹤0.01% 1695
2023
Q4 		– Sell
-22
Closed -$2.06K – 1340
2023
Q3 		$2.06K Buy
22
+9
+69% +$832 ﹤0.01% 1002
2023
Q2 		$1.19K Buy
+13
New +$1.07K ﹤0.01% 1085

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Arax Advisory Partners's AMED Position: Q3 2025 in Review

Arax Advisory Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 115 shares — an estimated $11.3K sold.

Arax Advisory Partners first reported a position in AMED in Q2 2023 and held it in 6 quarters. The position peaked at $120K in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Arax Advisory Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 115 Amedisys shares in Q3 2025, an estimated $11.3K.
  • Arax Advisory Partners first reported a position in Amedisys in Q2 2023 and held it in 6 quarters.
  • Arax Advisory Partners's Amedisys position peaked at $120K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.